Efficacy Study of Sodium Channel Blocker in LQT3 Patients
Status:
Completed
Trial end date:
2018-07-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether late sodium channel blockade might be
effective in shortening the QTc interval in various LQT3 mutations and be considered as a
safe therapeutic option for LQT3 patients.